Table 1.
Baseline characteristics of patients with cardiac myxoma.
| Variables | Total (n = 416) | CM-IS (n = 61) | CM-non IS (n = 355) | p-value |
|---|---|---|---|---|
| Age, years | 53.81 ± 13.87 | 56.17 ± 13.10 | 53.41 ± 13.97 | 0.151 |
| Female, n (%) | 258 (62.0) | 30 (49.2) | 228 (64.2) | 0.081 |
| Medical history, n (%) | ||||
| Hypertension | 126 (30.3) | 26 (42.6) | 100 (28.2) | 0.023 |
| Hyperlipidemia | 37 (8.9) | 12 (19.7) | 25 (7.0) | 0.001 |
| Diabetes mellitus | 47 (11.3) | 8 (13.1) | 39 (11.0) | 0.628 |
| Smoking status, n (%) | 0.355 | |||
| Non-smoker | 300 (72.1) | 39 (63.8) | 262 (73.8) | |
| Current smoker | 84 (20.2) | 15 (24.6) | 69 (19.4) | |
| Ex-smoker | 32 (7.7) | 7 (11.4) | 24 (7.0) | |
| Clinical feature, n (%) | ||||
| Cardiac symptoms | 229 (55.0) | 40 (65.5) | 209 (58.9) | <0.001 |
| Constitutional symptoms | 9 (2.2) | 0 (0) | 9 (2.5) | 1 |
| Systemic embolic symptoms | 10 (2.4) | 6 (9.8) | 4 (1.1) | <0.001 |
| Platelets counts (109/L) | 228.25 ± 83.44 | 253.35 ± 89.09 | 223.94 ± 81.79 | 0.011 |
| Echocardiography | ||||
| Length, mm | 36.41 ± 20.60 | 36.59 ± 20.79 | 36.38 ± 20.59 | 0.940 |
| Width, mm | 25.16 ± 15.47 | 22.78 ± 14.29 | 25.57 ± 15.62 | 0.193 |
| High mobility, n (%) | 149 (35.8) | 42 (68.6) | 107 (30.1) | 0.03 |
| Irregular surface, n (%) | 1 (0.2) | 0 (0) | 1 (0.3) | 1 |
| Stalk, n (%) | 301 (72.4) | 47 (77.0) | 254 (71.5) | 0.375 |
| LVEF, % | 61.17 ± 10.43 | 61.64 ± 9.52 | 60.09 ± 10.59 | 0.704 |
CM-IS, cardiac myxoma-related ischemic stroke; CM-non IS, cardiac myxoma without ischemic stroke; LVEF, left ventricular ejection fractions.